ADJUVANT BEVACIZUMAB IS SAFE TREATMENT FOR MELANOMA PATIENTS AT HIGH RISK OF RECURRENCE

S. Biswas, C. East, A. A'Hern, A. Marshall, J. Dunn, P. Lorigan, M. Middleton, P. Corrie

    Research output: Contribution to journalMeeting Abstractpeer-review

    Original languageUndefined
    Pages (from-to)245
    Number of pages1
    JournalAnnals of Oncology
    Volume19
    Publication statusPublished - Sept 2008
    Event33rd European-Society-for-Medical-Oncology Congress - Stockholm, Sweden
    Duration: 12 Sept 200816 Sept 2008

    Cite this